We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.2%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.9B
AUM Growth
-$468M
(-2.7%)
Cap. Flow
+$68M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
1,101
New
144
Increased
331
Reduced
453
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$319M |
| 2 |
Uber
UBER
|
+$90.8M |
| 3 |
Tyson Foods
TSN
|
+$81.8M |
| 4 |
Archer Daniels Midland
ADM
|
+$81.5M |
| 5 |
Travelers Companies
TRV
|
+$81.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$106M |
| 2 |
Lockheed Martin
LMT
|
+$88.6M |
| 3 |
Ross Stores
ROST
|
+$77.9M |
| 4 |
Hilton Worldwide
HLT
|
+$69.3M |
| 5 |
Cigna
CI
|
+$58.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.51% |
| 2 | Financials | 12.87% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 12.35% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLTH
801
DELISTED
Cue Health Inc. Common Stock
HLTH
| $499K | ﹤0.01% |
1,127,518
+243,246
| +28% | +$111K |
|
|
HTLF
802
DELISTED
Heartland Financial USA, Inc.
HTLF
| $492K | ﹤0.01% |
16,713
-4,972
| -23% | -$155K |
|
|
CMBM
803
DELISTED
Cambium Networks
CMBM
| $491K | ﹤0.01% |
66,992
-103,276
| -61% | -$1.12M |
|
804
CEVA Inc
CEVA
$883M
| $490K | ﹤0.01% |
25,264
-367
| -1% | -$8.52K |
|
805
Arch Capital
ACGL
$37.2B
| $488K | ﹤0.01% |
+6,119
| New | +$476K |
|
806
Precision BioSciences
DTIL
$185M
| $486K | ﹤0.01% |
47,485
+21,462
| +82% | +$330K |
|
807
Old Second Bancorp
OSBC
$1.3B
| $485K | ﹤0.01% |
35,643
-105
| -0.3% | -$1.53K |
|
808
Martin Marietta Materials
MLM
$35B
| $481K | ﹤0.01% |
+1,173
| New | +$519K |
|
809
Lyell Immunopharma
LYEL
$318M
| $478K | ﹤0.01% |
16,268
+11,289
| +227% | +$536K |
|
810
1st Source
SRCE
$2.18B
| $472K | ﹤0.01% |
11,209
-36
| -0.3% | -$1.6K |
|
|
IGMS
811
DELISTED
IGM Biosciences
IGMS
| $470K | ﹤0.01% |
56,237
-81,338
| -59% | -$690K |
|
812
Amalgamated Financial
AMAL
$1.49B
| $469K | ﹤0.01% |
27,243
-85
| -0.3% | -$1.54K |
|
813
Sierra Bancorp
BSRR
$536M
| $468K | ﹤0.01% |
24,708
+2,753
| +13% | +$54.1K |
|
814
Ginkgo Bioworks
DNA
$503M
| $464K | ﹤0.01% |
6,408
-86,593
| -93% | -$6.92M |
|
|
CASA
815
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $463K | ﹤0.01% |
546,492
-6,393
| -1% | -$6.21K |
|
816
Commercial Vehicle Group
CVGI
$152M
| $462K | ﹤0.01% |
59,497
-718
| -1% | -$6.77K |
|
|
LENZ
817
LENZ Therapeutics
LENZ
$184M
| $461K | ﹤0.01% |
26,578
| – | – |
|
818
nLIGHT
LASR
$3.57B
| $459K | ﹤0.01% |
44,095
-85,199
| -66% | -$1.04M |
|
819
Boeing
BA
$175B
| $457K | ﹤0.01% |
+2,385
| New | +$522K |
|
820
Adicet Bio
ACET
$76.7M
| $457K | ﹤0.01% |
20,850
+590
| +3% | +$20.8K |
|
821
Kodiak Sciences
KOD
$2.52B
| $455K | ﹤0.01% |
252,605
-17,532
| -6% | -$61.9K |
|
822
Lazard
LAZ
$4.21B
| $452K | ﹤0.01% |
+14,562
| New | +$488K |
|
823
Mercury Systems
MRCY
$5.97B
| $452K | ﹤0.01% |
+12,174
| New | +$449K |
|
824
Gates Industrial Corporation Ltd.
GTES
$6.69B
| $448K | ﹤0.01% |
38,621
+1,575
| +4% | +$19.6K |
|
825
Inovio Pharmaceuticals
INO
$84.7M
| $447K | ﹤0.01% |
95,831
-83,112
| -46% | -$459K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2023 Portfolio in Review
As of Q3 2023, Jacobs Levy Equity Management held 1,101 positions worth $16.9B, down 2.7% from $17.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2023 filing shows 144 new, 331 increased, 453 reduced and 149 closed positions. Its largest new stake was Tyson Foods: 1,536,421 shares worth $77.6M. The largest sale was Altria Group, an estimated $106M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q3 2023 buy was Tyson Foods: 1,536,421 shares worth $77.6M.
- Jacobs Levy Equity Management added most to NVIDIA in Q3 2023, an estimated $319M increase.
- Jacobs Levy Equity Management's biggest Q3 2023 reduction was Altria Group, cutting an estimated $106M.
- Jacobs Levy Equity Management fully exited Hilton Worldwide in Q3 2023, selling an estimated $69.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $16.9B portfolio in Q3 2023.
- Jacobs Levy Equity Management opened 144 new positions and closed 149 in Q3 2023.
- Jacobs Levy Equity Management's portfolio value fell 2.7% quarter-over-quarter to $16.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.